Human Reproduction, Vol. 14, No. 8, 2166-2169,
August 1999
© 1999 European Society of Human Reproduction and Embryology
Reproductive decisions of men with microdeletions of the Y chromosome: the role of genetic counselling
1 Department of Gynaecology and Obstetrics, 2 Department of Human Genetics, University Hospital Nijmegen, The Netherlands, 3 Department of Obstetrics and Gynaecology, University Hospital Gent, Belgium, 4 Laboratory of In vitro Fertilisation, University Hospital Dijkzigt, Rotterdam, 5 Clinical Genetics Centre, Utrecht and 6 Department of Obstetrics and Gynaecology, University Hospital Utrecht, The Netherlands
Couples dealing with microdeletions of the Y chromosome have to make decisions about their reproductive future. Do they opt for intracytoplasmic sperm injection (ICSI), artificial insemination with donor insemination (AID) or no treatment? We analysed this decision in 28 couples and investigated the role of the counsellor and the counselling process on the final decision of the couple. Ten counsellors from six fertility clinics in The Netherlands and Belgium were interviewed about their genetic counselling of couples dealing with microdeletions. The answers to the questionnaire were converted to 11 dichotomous variables. Of the 1627 tested men in the six centres, 37 (2.3%) had a microdeletion in the AZFc region, a subregion of the AZF region on the Y chromosome important for normal spermatogenesis. The decisions of 28 of them could be analysed. Most couples chose ICSI (79%). The remaining couples chose donor insemination (7%) or refrained from treatment (14%). Several variables, including the counselling procedure, the counsellor and the available treatments in the fertility centre, influenced the decision of the couple. In conclusion, most couples dealing with microdeletions in the AZF region choose ICSI. Several aspects of the process of genetic counselling appear to be related to the final decision.
Key words: assisted reproduction/genetic counselling/ICSI/male infertility/microdeletions
7 To whom correspondence should be addressed at: Department of Gynaecology and Obstetrics, University Hospital Nijmegen,PO Box 9101, 6500 HB Nijmegen, The Netherlands
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. R. Schover Rates of Postcancer Parenthood J. Clin. Oncol., January 20, 2009; 27(3): 321 - 322. [Full Text] [PDF] |
||||
![]() |
K. Aittomaki, U.-B. Wennerholm, C. Bergh, A. Selbing, J. Hazekamp, and K.-G. Nygren Safety issues in assisted reproduction technology: Should ICSI patients have genetic testing before treatment? A practical proposition to help patient information Hum. Reprod., March 1, 2004; 19(3): 472 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Peterlin, T. Kunej, J. Sinkovec, N. Gligorievska, and B. Zorn Screening for Y chromosome microdeletions in 226 Slovenian subfertile men Hum. Reprod., January 1, 2002; 17(1): 17 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Simoni Molecular diagnosis of Y chromosome microdeletions in Europe: state-of-the-art and quality control Hum. Reprod., March 1, 2001; 16(3): 402 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J.T. van Golde, A. M.M. Wetzels, R. de Graaf, J. H.A.M. Tuerlings, D. D.M. Braat, and J. A.M. Kremer Decreased fertilization rate and embryo quality after ICSI in oligozoospermic men with microdeletions in the azoospermia factor c region of the Y chromosome Hum. Reprod., February 1, 2001; 16(2): 289 - 292. [Abstract] [Full Text] [PDF] |
||||

